The effect of heterogeneity on optimal regimens in cancer chemotherapy (Q1408746): Difference between revisions
From MaRDI portal
Removed claims |
ReferenceBot (talk | contribs) Changed an Item |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Property / author | |||
| Property / author: John M. Murray / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Andrew J. Coldman / rank | |||
Normal rank | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: A model for the resistance of tumor cells to cancer chemotherapeutic agents / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Optimal control for a stochastic model of cancer chemotherapy / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Q5532825 / rank | |||
Normal rank | |||
Latest revision as of 10:25, 6 June 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The effect of heterogeneity on optimal regimens in cancer chemotherapy |
scientific article |
Statements
The effect of heterogeneity on optimal regimens in cancer chemotherapy (English)
0 references
25 September 2003
0 references
cancer chemotherapy
0 references
optimal regimen
0 references
heterogeneity
0 references
0 references
